Fycompa 4mg Tablet contains Perampanel, an antiepileptic medication used primarily to treat partial-onset seizures and primary generalized tonic-clonic seizures in patients with epilepsy. Perampanel works by selectively blocking AMPA receptors in the brain, which are involved in excitatory neurotransmission, thereby reducing the excessive neuronal activity that leads to seizures. Fycompa is typically prescribed as an adjunctive therapy for patients aged 12 years and older who have not achieved adequate seizure control with other antiepileptic drugs. The 4mg dosage allows for flexible titration based on individual patient response and tolerability. Common side effects may include dizziness, somnolence, irritability, and headache, while serious adverse effects can involve mood changes or aggressive behavior, necessitating careful monitoring by healthcare providers. It is important to take Fycompa exactly as prescribed, usually once daily at bedtime, to maintain consistent blood levels and minimize side effects. Patients should avoid alcohol and inform their doctor about any other medications they are taking to prevent potential drug interactions. Fycompa should not be discontinued abruptly without medical advice, as this may increase seizure frequency. Overall, Fycompa 4mg Tablet is an effective option for managing epilepsy when used under proper medical supervision.